Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy-Reference-Cited by-同舟云学术

Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy

Published:2011-05 Issue:4 Volume:27 Page:392-401
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab. Res. Rev.

Author:

Henriksen Kim,Byrjalsen Inger,Qvist Per,Beck-Nielsen Henning,Hansen Gitte,Riis Bente J.,Perrild Hans,Svendsen Ole Lander,Gram Jeppe,Karsdal Morten A.,Christiansen Claus,

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.1187/fullpdf

Reference28 articles.

1. World Health Organization WHO Diabetes. Fact sheet no 312 2008

2. Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress;Cho;Curr Top Med Chem,2008

3. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial;Home;Lancet,2009

4. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials;Lincoff;JAMA,2007

5. 10-Year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone Mineral Density in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-07-22

2. Effects of telmisartan on metabolic syndrome components: a comprehensive review;Biomedicine & Pharmacotherapy;2024-02

3. The PPAR System in Diabetes;Contemporary Diabetes;2023

4. Dihydropyrazinoquinazolinones via S_N2 Sulfamidate Ring-Opening and a Sequential Quinazolinone–Amidine Rearrangement Strategy (SQuAReS);The Journal of Organic Chemistry;2022-10-04

5. Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs;European Journal of Pharmacology;2022-02